Some of the European Union's biggest nations have restarted their roll-out of the Oxford-AstraZeneca vaccine after the medicines regulator concluded it was safe and effective. Ros Atkins considers how a vaccine initially hailed as a "gamechanger", has ended up in the middle of a scientific and political storm.
